Tag: Cancer: Breast
Local Recurrence Rate Low With Radiation Boost in Breast Cancer Patients
For young patients, high boost dose yields slightly better local control, but increased incidence of fibrosis in boost area
Annual Breast Cancer Screening From Ages 40 to 79 Years Is Best Strategy
Annual screening appears to provide the greatest benefit and lowest risk
Enobosarm Has Antitumor Activity in ER-Positive, HER2-Negative Advanced Breast Cancer
At 24 weeks, 32 and 29 percent of patients in the 9-mg and 18-mg groups had clinical benefit
Low-Dose Positron Emission Mammography Helps ID Breast Cancer
In a cohort of 25 women newly diagnosed with breast cancer, 24 cancers were identified with PEM
Race Can Affect Breast Cancer Test for Predicting Chemo Benefit
21-gene recurrence score may underestimate benefit of chemotherapy for young non-Hispanic Black women with ER-positive, axillary node-negative breast cancer
Single-Port Robotic System Feasible for Nipple-Sparing Mastectomy
No immediate operative or oncologic complications seen, with high skin, nipple sensation preservation
Invasive Breast Cancer, Breast Cancer Mortality Increased Long Term After DCIS
Highest cumulative risks for invasive breast cancer and breast cancer death seen for women aged younger than 45 years at diagnosis
Soy, Enterolactone, Green Tea May Reduce Adverse Breast Cancer Outcomes
Reduced risk for recurrence seen in association with soy isoflavones; prediagnostic green tea also linked to reduced risk for recurrence
1975 to 2019 Saw 58 Percent Decrease in Breast Cancer Mortality
Of the reduction, 29 percent was due to treatment of metastatic breast cancer, 25 percent due to mammography screening
Clinical Breast Exam Rarely Detects Second Breast Cancer After DCIS
Second breast cancers were most often imaging-detected or patient-detected, with only 2.2 percent detected by physician
